MS&AD Insurance Group (OTCMKTS:MSADY - Get Free Report) announced its quarterly earnings results on Friday. The insurance provider reported $0.57 earnings per share (EPS) for the quarter, Zacks reports. The firm had revenue of $11.70 billion during the quarter.
MS&AD Insurance Group Price Performance
OTCMKTS MSADY traded down $0.56 on Tuesday, hitting $21.03. The stock had a trading volume of 47,236 shares, compared to its average volume of 74,995. The firm has a 50-day moving average of $21.24 and a 200-day moving average of $22.18. The company has a debt-to-equity ratio of 0.14, a quick ratio of 0.26 and a current ratio of 0.26. MS&AD Insurance Group has a 52-week low of $15.52 and a 52-week high of $24.74. The company has a market capitalization of $33.82 billion, a price-to-earnings ratio of 14.21 and a beta of 0.49.
About MS&AD Insurance Group
(
Get Free Report)
MS&AD Insurance Group Holdings, Inc, an insurance holding company, provides insurance and financial services worldwide. The company offers domestic non-life insurance; life insurance; international business; financial services; and provides risk-related services. The company was formerly known as Mitsui Sumitomo Insurance Group Holdings, Inc and changed its name to MS&AD Insurance Group Holdings, Inc in April 2010.
Featured Stories
Before you consider MS&AD Insurance Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MS&AD Insurance Group wasn't on the list.
While MS&AD Insurance Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
